scispace - formally typeset
X

Xianqi Li

Researcher at Matsumoto Dental University

Publications -  16
Citations -  107

Xianqi Li is an academic researcher from Matsumoto Dental University. The author has contributed to research in topics: Bone regeneration & Mesenchymal stem cell. The author has an hindex of 5, co-authored 12 publications receiving 65 citations.

Papers
More filters
Journal ArticleDOI

Enhanced bone regeneration capability of chitosan sponge coated with TiO2 nanoparticles

TL;DR: Chitosan hybridized with titanium dioxide nanoparticles improves its bone regeneration capability and results in significantly improved sponge robustness, biomineralization, and bone regeneration capabilities, as indicated by DMP1 and OCN gene upregulation in chitosAn-50% nanoTiO2 sample.
Journal ArticleDOI

Comparing immunocompetent and immunodeficient mice as animal models for bone tissue engineering

TL;DR: Bone regeneration was feasible in immunocompetent and immunodeficient mice, however, some differences were observed in the bone regeneration process possibly due to different cytokine expression, which should be considered when utilizing in vivo animal models.
Journal ArticleDOI

Spontaneously Formed Spheroids from Mouse Compact Bone-Derived Cells Retain Highly Potent Stem Cells with Enhanced Differentiation Capability

TL;DR: Spontaneously formed spheroids expressed stem cell markers and showed enhanced osteogenic and neurogenic differentiation capabilities than cells from the conventional monolayer culture, which supports the superior stemness.
Journal ArticleDOI

Characterization of spontaneous spheroids from oral mucosa-derived cells and their direct comparison with spheroids from skin-derived cells

TL;DR: Both spheroid-forming cell types had the ability to differentiate into neural and Schwann cells after neurogenic induction, although significantly higher MAP 2, MBP, Nestin, and Nurr1 gene expression was noted in the cells from oral mucosa-derived spheroids.
Journal ArticleDOI

Issues with the surgical treatment of antiresorptive agent-related osteonecrosis of the jaws.

TL;DR: Issues regarding the current surgical treatment for antiresorptive agent-related osteonecrosis of the jaws are discussed, with an emphasis on the clinical aspects.